Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)

doi:10.1080/14796694.2024.2440277

Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)

School of Medicine and Psychology

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	627-636
Number of pages	10
Journal	Future Oncology
Volume	21
Issue number	6
DOIs	https://doi.org/10.1080/14796694.2024.2440277
Publication status	Published - 1 Mar 2025

Access to Document

10.1080/14796694.2024.2440277

Cite this

@article{8b4ee623ce5c467092ea39983354a48e,

title = "Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)",

author = "Ciara Conduit and Inderjeeth, {Andrisha Jade} and Raymond Allen and Martin, {Andrew J.} and Wendy Parulekar and Eibhlin Mulroe and Margaret McJannett and Zielinski, {Robert R.} and Alastair Thomson and Tan, {Thean Hsiang} and Sandhu, {Shahneen K.} and Reaume, {M. Neil} and Pook, {David W.} and North, {Scott A.} and Marx, {Gavin M.} and Anthony Joshua and Lisa Horvath and Ray McDermott and Simon Chowdhury and Chi, {Kim N.} and Zhang, {Alison Y.} and Stockler, {Martin R.} and Davis, {Ian D.} and Sweeney, {Christopher J.}",

year = "2025",

month = mar,

day = "1",

doi = "10.1080/14796694.2024.2440277",

language = "English",

volume = "21",

pages = "627--636",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Taylor and Francis Ltd.",

number = "6",

}

TY - JOUR

T1 - Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer

T2 - a plain language summary of the ENZAMET trial (ANZUP 1304)

AU - Conduit, Ciara

AU - Inderjeeth, Andrisha Jade

AU - Allen, Raymond

AU - Martin, Andrew J.

AU - Parulekar, Wendy

AU - Mulroe, Eibhlin

AU - McJannett, Margaret

AU - Zielinski, Robert R.

AU - Thomson, Alastair

AU - Tan, Thean Hsiang

AU - Sandhu, Shahneen K.

AU - Reaume, M. Neil

AU - Pook, David W.

AU - North, Scott A.

AU - Marx, Gavin M.

AU - Joshua, Anthony

AU - Horvath, Lisa

AU - McDermott, Ray

AU - Chowdhury, Simon

AU - Chi, Kim N.

AU - Zhang, Alison Y.

AU - Stockler, Martin R.

AU - Davis, Ian D.

AU - Sweeney, Christopher J.

PY - 2025/3/1

Y1 - 2025/3/1

UR - http://www.scopus.com/inward/record.url?scp=86000674119&partnerID=8YFLogxK

U2 - 10.1080/14796694.2024.2440277

DO - 10.1080/14796694.2024.2440277

M3 - Article

C2 - 39819293

AN - SCOPUS:86000674119

SN - 1479-6694

VL - 21

SP - 627

EP - 636

JO - Future Oncology

JF - Future Oncology

IS - 6

ER -

Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)

Access to Document

Other files and links

Cite this